Literature DB >> 24469838

Group G streptococcal sepsis, septic arthritis and myositis in a patient with severe oral ulcerations.

Wu Deng1, Laurie Farricielli.   

Abstract

Lancefield group G streptococci (GGS) are a relatively less common cause of streptococcal infections but the incidence of which has been reported to increase in the recent years. Similar to group A streptococci, GGS produce localised and invasive infections. Streptococcal myositis is a very rare but highly fatal infection of muscles generally caused by group A streptococci. We report a case of sepsis, migrating septic arthritis and diffuse myositis caused by β-haemolytic GGS. It is an unusual case of diffuse β-haemolytic GGS myositis involving multiple muscle groups in a patient who demonstrated no skin lesions or sign of streptococcal toxic shock syndrome. The patient responded well to intravenous antibiotics without surgical intervention and experienced full recovery.

Entities:  

Mesh:

Year:  2014        PMID: 24469838      PMCID: PMC3912390          DOI: 10.1136/bcr-2013-200338

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  24 in total

1.  Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes.

Authors:  Jun Sawai; Tadao Hasegawa; Takuya Kamimura; Akira Okamoto; Daisuke Ohmori; Nobuyuki Nosaka; Keiko Yamada; Keizo Torii; Michio Ohta
Journal:  Antimicrob Agents Chemother       Date:  2006-11-13       Impact factor: 5.191

2.  Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects.

Authors:  K Ekelund; P Skinhøj; J Madsen; H B Konradsen
Journal:  Clin Microbiol Infect       Date:  2005-07       Impact factor: 8.067

3.  Clindamycin in the treatment of group G beta-haemolytic streptococcal infections.

Authors:  A Pillai; S Thomas; C Williams
Journal:  J Infect       Date:  2005-11       Impact factor: 6.072

4.  Acute group G streptococcal myositis associated with streptococcal toxic shock syndrome: case report and review.

Authors:  J G Wagner; P M Schlievert; A P Assimacopoulos; J A Stoehr; P J Carson; K Komadina
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

5.  Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci.

Authors:  E M Mascini; M Jansze; L M Schouls; J Verhoef; H Van Dijk
Journal:  Int J Antimicrob Agents       Date:  2001-10       Impact factor: 5.283

Review 6.  Beta-haemolytic group A, B, C and G streptococcal septicaemia: a clinical study.

Authors:  K Skogberg; H Simonen; O V Renkonen; V V Valtonen
Journal:  Scand J Infect Dis       Date:  1988

7.  Antibiotic susceptibilities of group C and group G streptococci isolated from patients with invasive infections: evidence of vancomycin tolerance among group G serotypes.

Authors:  T Zaoutis; B Schneider; L Steele Moore; J D Klein
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

8.  Infections due to Lancefield group G streptococci.

Authors:  C Vartian; P I Lerner; D M Shlaes; K V Gopalakrishna
Journal:  Medicine (Baltimore)       Date:  1985-03       Impact factor: 1.889

9.  Analysis of a viridans group strain reveals a case of bacteremia due to lancefield group G alpha-hemolytic Streptococcus dysgalactiae subsp equisimilis in a patient with pyomyositis and reactive arthritis.

Authors:  Patrick C Y Woo; Jade L L Teng; Susanna K P Lau; Peggy N L Lum; Kit-Wah Leung; Kee-Lam Wong; Kin-Wah Li; Kui-Chun Lam; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 10.  Pyomyositis in a patient with progressive systemic sclerosis. Case report and review of the literature.

Authors:  R L Minor; S Baum; K S Schulze-Delrieu
Journal:  Arch Intern Med       Date:  1988-06
View more
  4 in total

1.  Streptococcus dysagalactiae pyomyositis.

Authors:  Norihiko Terada; Yuzuru Hamada; Yasuharu Tokuda
Journal:  J Gen Fam Med       Date:  2017-05-29

Review 2.  Secondary myopathy due to systemic diseases.

Authors:  J Finsterer; W N Löscher; J Wanschitz; S Quasthoff; W Grisold
Journal:  Acta Neurol Scand       Date:  2016-02-25       Impact factor: 3.209

3.  Recurrent group G Streptococcus bacteremia: A case report and literature review.

Authors:  Haider Ghazanfar; Zaheer Qureshi; Harika Kalangi; Subhan Ata; Abhilasha Jyala; Esther Arguello Perez
Journal:  Clin Case Rep       Date:  2022-08-08

4.  Group G streptococcal myositis in a patient with myeloproliferative neoplasm.

Authors:  Monica Midha; Marnie E Rosenthal
Journal:  IDCases       Date:  2016-07-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.